A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Scope: | Endocrine disrupting properties (Article 57(f) - human health) |
---|---|
Status: | Under decision making by the European Commission |
Submitter: | France |
Date of intention: | 2019-08-12 |
CLP Annex VI Index Number: | 604-010-00-1 |
Expected date of submission: | 2020-02-03 |
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
March 31, 2021
- Name: resorcinol; 1,3-benzenediol → 1,3-benzenediol;resorcinol
April 8, 2021
- Name: 1,3-benzenediol;resorcinol → resorcinol; 1,3-benzenediol
This version
July 2, 2020
- Scope: Endocrine disrupting properties (Article 57(f) – human health) → Endocrine disrupting properties (Article 57(f) - human health)
- Status: Intention → Under decision making by the European Commission
Feb. 27, 2020
- Name: Resorcinol → resorcinol; 1,3-benzenediol
Add the related substance to your watchlist to monitor this regulatory record.